Status checked June 2026 Regulatory status can change
Blood test markers to discuss with a clinician Marker Comprehensive metabolic panel (CMP) Why it matters Reviews liver enzymes, kidney markers, electrolytes, and glucose in one broad safety panel
The studies tested various doses including 0.25 mg, 0.5 mg, and 1 mg daily via subcutaneous administration over periods ranging from single doses to 24 weeks of continuous therapy
However, because AOD9604 is often selfadministered outside clinical settings, the safety margin can vary depending on sourcing, dosing accuracy, and overall protocol design
5-Amino-1MQ Timeline & What to Monitor 5-Amino-1MQ works through slow metabolic changes inside fat cells, not through appetite suppression